Portfolio company
Lentitek
United Kingdom · £1.7m raised
Raised
£1.7m
Latest stage
Seed
Rounds recorded
2
Backed by
4 investors
Sectors
About
This company develops manufacturing technologies for lentiviral vectors to help cell and gene therapy developers improve the production of advanced cancer treatments.
SourceFunding history · 2
Similar companies
Ori Biotech
This company develops automated manufacturing platforms for cell and gene therapy developers to scale production of advanced medicines.
Cellevate
This company develops nanofiber cell culture microcarriers for biopharmaceutical manufacturers to enhance viral vaccine and gene therapy production yields.
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Ventuno Biotech
This biotechnology company develops cancer immunotherapies to stimulate the immune system and treat patients with difficult tumours.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
T-CURX
This biotech company develops non-viral CAR-T cell therapies to treat patients with leukaemia, lymphoma and solid tumours.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
